The Effect of Aldose Reductase Inhibition and Dietary Protein Restriction on Renal Function in Experimental Diabetes Mellitus

References

• Greene D A, Lattimer S A, Sima A AF. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. New Engl J Med 1987; 316: 599–606
   PubMed Web of Science ®Google Scholar
• Peterson M J, Sarges R, Aldinger C E, MacDonald D P. CP-45,634 a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats. Metabolism 1979; 28(Suppl. 1)456–461
   PubMedGoogle Scholar
• Robinson W G, Kador P F, Kinoshita J H. Retinal capillaries: basement membrane thickening by galactosemia prevented with aldose reductase inhibitor. Science 1983; 221: 1177–1179
   PubMed Web of Science ®Google Scholar
• Tomlinson D R, Holmes P R, Mayer J H. Reversal, by treatment with an aldose reductase inhibitor, of impaired axonal transport and motor nerve conduction velocity in experimental diabetes mellitus. Neurosci Lett 1982; 31: 189–193
   PubMed Web of Science ®Google Scholar
• Beyer-Mears A, Ku L, Cohen M P. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil. Diabetes 1984; 33: 604–607
   PubMedGoogle Scholar
• Cohen M P, Dasmahapatra A, Shapiro E. Reduced glomerular sodium/potassium adenosine triphosphatase activity in acute streptozocin diabetes and its prevention by oral sorbinil. Diabetes 1985; 34: 1071–1074
   Google Scholar
• Cohen R A, MacGregor L C, Spokes K C, Silva P, Epstein F H. Role of myo-inositol in renal Na-K-ATPase changes produced by diabetes (Abstract). Kidney Int 1988; 33: 372
   Google Scholar
• Goldfarb S, Simmons D A, Kern E. Amelioration of glomerular hyperfiltration in acute experimental diabetes by dietary myoinositol supplementation and aldose reductase inhibition. Trans Assoc Am Physicians 1986; 99: 67–72
   Google Scholar
• Tilton R G, Chang K, Pugliese G, Kilo C, Williamson J R. Inhibitors of aldose reductase block diabetes-induced increases in blood flow and GFR and markedly reduce 24 h urinary albumin excretion in the rat (Abstract). Diabetes 1987; 36(Suppl. 1)43A
   Google Scholar
• Craven P A, DeRubertis F R. Sorbinil suppresses glomerular prostaglandin production and reduces hyperfiltration in the streptozotocin diabetic rat (Abstract). Clin Res 1988; 36: 517A
   Google Scholar
• Murray B M. Effect of dietary protein on renal vascular reactivity in the rat (Abstract). Kidney Int 1987; 31: 425
   Google Scholar
• Paller M S, Hostetter T H. Dietary protein increases plasma renin and reduces pressor reactivity to angiotensin II. Am J Physiol 1986; 251: F34–39
   PubMed Web of Science ®Google Scholar
• Murray B M. High protein diet impairs autoregulation and renal vascular reactivity in the normal kidney (Abstract). Abstracts of the Xth International Congress of Nephrology, A M Davison. The Alden Press, Oxford 1987; 558
   Google Scholar
• Zatz R, Meyer T W, Rennke H G, Brenner B M. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci USA 1985; 82: 5963–5967
   PubMed Web of Science ®Google Scholar
• Wen S F, Huang T P, Moorthy A V. Effects of low-protein diet on experimental diabetic nephropathy in the rat. J Lab Clin Med 1985; 106: 589–597
   Google Scholar
• Steffes M W, Brown D M, Mauer S M. Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes 1978; 27: 35–41
   PubMed Web of Science ®Google Scholar
• Mancini G, Carbonara A O, Heremans J F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 235–254
   PubMedGoogle Scholar
• Kupin W L, Cortes P, Dumler F, Feldkamp C S, Kilates M C, Levin N W. Effect on renal function of change from high to moderate protein intake in type I diabetic patients. Diabetes 1987; 36: 73–79
   PubMedGoogle Scholar
• Bosch J P, Asccaggi A, Lauer A, Ronco C, Belledonne M, Glabman S. Renal functional reserve in humans: effect of protein on glomerular filtration rate. Am J Med 1983; 75: 943–950
   PubMed Web of Science ®Google Scholar
• Neugarten J, Liu D, Feiner H, Schacht R G, Baldwin D S. Role of hyperphagia in experimental diabetic nephropathy (Abstract). Kidney Int 1986; 29: 324
   Google Scholar
• Wiseman M J, Bognetti E, Dodds R, Viberti G C. Glycemia and dietary protein in the modulation of glomerular filtration rate and albuminuria in insulin-dependent diabetes (Abstract). Kidney Int 1986; 29: 389
   Google Scholar
• Bending J J, Dodds R A, Keen H, Viberti G C. Renal response to restricted protein intake in diabetic nephropathy. Diabetes 1988; 37: 1641–1646
   Google Scholar
• Christiansen J S, Gammelgaard J, Tronier B, Svendsen P A, Parving H -H. Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int 1982; 21: 683–688
   PubMed Web of Science ®Google Scholar
• Wiseman M J, Saunders A J, Keen H, Viberti G C. Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes. N Engl J Med 1985; 312: 617–621
   PubMed Web of Science ®Google Scholar
• Seyer-Hansen K. Renal hypertrophy in streptozotocin-diabetic rats. Clin Sci Mol Med 1976; 51: 551–555
   PubMedGoogle Scholar
• Hostetter T H, Troy J L, Brenner B M. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981; 19: 410–415
   PubMed Web of Science ®Google Scholar
• Michels L D, Davidman M, Keane W F. Determinants of glomerular filtration and plasma flow in experimental diabetic rats. J Lab Clin Med 1981; 98: 869–885
   PubMed Web of Science ®Google Scholar
• Kreisberg J I, Patel P Y. The effects of insulin, glucose and diabetes on prostaglandin production by rat kidney glomeruli and cultured glomerular mesangial cells. Prostaglandins Leukotrienes Med 1983; 11: 431–442
   Google Scholar
• Schambelan M, Blake S, Sraer J, Bens M, Nizez M -P, Wahbe F. Increased prostaglandin production by glomeruli isoplated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest 1985; 75: 404–412
   Google Scholar
• Rogers S P, Larkins R G. Production of 6-oxo-prostaglandin F1a and prostaglandin E2 by isolated glomeruli from normal and diabetic rats. Br Med J 1982; 284: 1215–1217
   Google Scholar
• Craven P A, Caines M A, DeRubertis F R. Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats: relationship by hyperfiltration of early diabetes. Metabolism 1987; 36: 95–103
   PubMed Web of Science ®Google Scholar
• Jensen P K, Steven K, Blaehr H, Christiansen J S, Parving H H. Effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int 1986; 29: 490–495
   PubMedGoogle Scholar
• Dyck P J, Zimmerman Br, Vilen T H, Minnerath S R, Karnes J L, Yao J K, Poduslo J F. Nerve glucose, fructose, sorbitol, myoinositol, and fiber degeneration and regeneration in diabetic neuropathy. N Engl J Med 1988; 319: 542–548
   PubMed Web of Science ®Google Scholar
• Wilkes B, Silverman S. Metabolic factors in the development and reversal of hyperfiltration in diabetic rats (Abstract). Kidney Int 1988; 33: 387
   Google Scholar
• Goldfarb S, Kern E O, Simmons D. Evidence that alterations in myo-inositol metabolism contribute to glomerular hyperfiltration in experimental diabetes mellitus (Abstract). Abstracts of the Xth International Congress of Nephrology, A M Davison. The Alden Press, Oxford 1987; 504
   Google Scholar
• Winegrad A I. Does a common mechanism induce the diverse complications of diabetes?. Diabetes 1987; 36: 396–406
   PubMed Web of Science ®Google Scholar
• Hostetter T H. Aldose reductase inhibitor does not ameliorate glomerular damage in diabetic rats (Abstract). Clin Res 1988; 36: 594A
   Google Scholar